Introduction:

Posner-Schlossman syndrome (PSS), also known as glaucomatocyclitic crisis, is a rare and recurring condition characterized by recurrent episodes of unilateral elevated intraocular pressure (IOP) accompanied by mild to moderate anterior chamber inflammation. This article provides a comprehensive overview of Posner-Schlossman syndrome, including its clinical features, diagnosis, management, and prognosis. Understanding this syndrome is crucial for ophthalmologists and healthcare professionals involved in the care of patients with glaucoma and uveitis.

Clinical Features of Posner-Schlossman Syndrome:

• Unilateral Presentation: PSS typically affects one eye, with the other eye remaining unaffected or rarely developing similar symptoms.
• Elevated Intraocular Pressure (IOP): Patients experience intermittent or sustained episodes of elevated IOP, which can be significantly high, reaching levels greater than 40 mmHg.
• Mild Anterior Chamber Inflammation: Mild to moderate anterior chamber inflammation characterized by fine keratic precipitates (KPs), cells in the anterior chamber, and mild flare.
• Recurrent Episodes: PSS is characterized by recurrent episodes of elevated IOP, typically lasting a few days to weeks, followed by periods of normal IOP and quiescence.

Diagnosis and Differential Diagnosis:

• Clinical Evaluation: The diagnosis of PSS is primarily based on clinical features, including unilateral elevated IOP, mild anterior chamber inflammation, and recurrent episodes.
• Differential Diagnosis: PSS should be differentiated from other causes of secondary glaucoma and uveitis, such as herpetic keratouveitis, Fuchs uveitis syndrome, and Posner-Schlossman-like syndrome associated with cytomegalovirus infection.

Management of Posner-Schlossman Syndrome:

• IOP Control: The primary goal of management is to control elevated IOP and prevent optic nerve damage. Topical and/or oral medications, including topical steroids and antiglaucoma medications, are commonly used to lower IOP during acute episodes.
• Anti-inflammatory Treatment: Topical corticosteroids are prescribed to manage the mild anterior chamber inflammation during active episodes.
• Monitoring and Follow-up: Regular monitoring of IOP and anterior chamber inflammation is necessary to detect recurrences and adjust the treatment plan accordingly.
• Surgical Intervention: In refractory cases or when medical management fails to control IOP adequately, surgical interventions such as trabeculectomy or glaucoma drainage devices may be considered.

Prognosis and Complications:

• Visual Prognosis: With appropriate management, most patients with Posner-Schlossman syndrome maintain good visual acuity, and the prognosis for long-term visual outcome is generally favorable.
• Complications: Complications may include visual field defects, glaucomatous optic neuropathy, and potential side effects of long-term use of topical medications.

Conclusion:

Posner-Schlossman syndrome is a rare and recurrent condition characterized by unilateral elevated IOP and mild anterior chamber inflammation. Early diagnosis and appropriate management are crucial to prevent optic nerve damage and preserve visual function. Ophthalmologists should be familiar with the clinical features, diagnosis, and management strategies for this unique syndrome to provide optimal care for affected individuals.

Hashtags: #PosnerSchlossmanSyndrome #GlaucomatocycliticCrisis #ElevatedIOP #AnteriorChamberInflammation #Ophthalmology